Simon Kerry – Experienced Biotech CEO and Entrepreneur , Advent Life Sciences

    • Simon Kerry – Experienced Biotech CEO and Entrepreneur , Advent Life Sciences's presentations

    Simon is a business professional with two decades’ experience of creating and developing innovative life science businesses. Simon is currently an Operating partner at Advent Life Sciences and is the Executive Chairman of Itara Therapeutics Ltd and Encipher Biotherapeutics Ltd. From 2006 to 2017 Simon was the CEO of Karus Therapeutics, taking the company from start-up to clinical-stage company. Before joining Karus he was Director of Business Development at Ablynx NV (Ghent, Belgium), where he was responsible for securing a number of research, development and licensing agreements with major pharmaceutical companies including Pfizer and Novartis. He also played a key role in Ablynx’s development from early-stage to one of Europe’s most promising antibody fragment companies.

    Prior to Ablynx, Simon was Director of Business Development at Active Biotech AB (Lund, Sweden), where he spun-out the molecular evolution company, Isogenica Ltd (Cambridge, UK), later joining the spin-out as Vice President of Business Development.

    Simon has held other key commercial appointments at Actinova Ltd (Cambridge UK), and Actigen Ltd (Cambridge, UK). He has also occupied senior commercial roles at the Health Protection Agency (Salisbury, UK) and within the Jasmin group of companies. Simon has a medicinal chemistry degree, a life science PhD and an executive MBA from Loughborough University Business School.



Leave a Reply


Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.